ResearcherMayo ClinicNo recent work listed
Robert Clell Miller
Matched on ORCID iD 0000-0001-8932-2732; OpenAlex author ID A5091023123. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers
Papers 6
- Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Co-author DOI 10.1016/j.tranon.2018.08.017↗
- Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Co-author DOI 10.1186/s12885-019-5790-2↗
- Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2015.11.003↗
- Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. Co-author PMID 26026108↗
- Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2014.07.024↗
- Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent… Last author DOI 10.1097/coc.0b013e3181f946fc↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William F. Regine · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Gian Carlo Mattiucci · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Felipe Ángel Calvo · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Alessio Giuseppe Morganti · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Sergio Alfieri · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Joseph M. Herman · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Vincenzo Valentini · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Massimo Falconi · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Michele Reni · 4 shared papers, 2014–2019 · strength 0.21
- Paper Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. DOI 10.1016/j.tranon.2018.08.017↗
- Paper Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. DOI 10.1186/s12885-019-5790-2↗
- Paper Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. PMID 26026108↗
- Lorenzo Fuccio · 2 shared papers, 2019 · strength 0.14
- Riccardo Casadei · 2 shared papers, 2019 · strength 0.14
- Gabriella Macchia · 2 shared papers, 2019 · strength 0.14
- Milly Buwenge · 2 shared papers, 2019 · strength 0.14
- Francesco Cellini · 2 shared papers, 2019 · strength 0.14
- Francesco Minni · 2 shared papers, 2019 · strength 0.14
- Alessandra Arcelli · 2 shared papers, 2019 · strength 0.14
- Stefano Partelli · 2 shared papers, 2015–2019 · strength 0.11
- Christopher Leigh Hallemeier · 2 shared papers, 2011–2016 · strength 0.10
- Paper Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.11.003↗
- Paper Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with su… DOI 10.1097/coc.0b013e3181f946fc↗
- Michael G. Haddock · 2 shared papers, 2011–2016 · strength 0.10
- Paper Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.11.003↗
- Paper Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with su… DOI 10.1097/coc.0b013e3181f946fc↗
- S. Cammelli · 1 shared paper, 2019 · strength 0.07
- Savino Cilla · 1 shared paper, 2019 · strength 0.07
- Paolo Passoni · 1 shared paper, 2019 · strength 0.07
- Mariacristina Di Marco · 1 shared paper, 2019 · strength 0.07
- Michael L. Kendrick · 1 shared paper, 2016 · strength 0.07
- Kenneth Wing Merrell · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.